Loading cancer entity…
Loading cancer entity…
Clinical trials
274 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (41)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT04022772 | Effect of PACK Health Support Program on Patient Reported Outcomes in Patients With Breast Cancer | completed | N/A | 287 | M.D. Anderson Cancer CenterOTHER | 1 | Aug 7, 2023 | clinicaltrials |
| NCT04722692 | Delayed Sentinel Lymph Node Biopsy in Ductal Cancer in Situ(SENTINOT_2) | recruiting | Phase 3 | 500 | Uppsala UniversityOTHER | 3 | Aug 3, 2023 | clinicaltrials |
| NCT05961280 |
| Selective Omission of Sentinel Lymph Node Biopsy in Mastectomy for Ductal Carcinoma in Situ: Identifying Eligible Candidates |
| completed |
| — |
| 385 |
| Gangnam Severance HospitalOTHER |
| 0 |
| Jul 27, 2023 |
| clinicaltrials |
| NCT05584332 | A Phase Ⅲ Study to Evaluate the Efficacy, Immunogenicity, Safety of Quadrivalent HPV Recombinant Vaccine in Chinese Healthy Females | terminated | Phase 3 | 3,131 | Shanghai Bovax Biotechnology Co., Ltd.INDUSTRY | 1 | Jul 21, 2023 | clinicaltrials |
| NCT05932758 | Excisional Vacuum-Assisted Breast Biopsy | unknown | N/A | 300 | European Institute of OncologyOTHER | 1 | Jul 21, 2023 | clinicaltrials |
| NCT02121873 | The Breast Duct: Pilot Study of Genomic Sequencing of Exfoliated Ductal Cells Obtained Through Endoscopy and Lavage | completed | — | 6 | Atossa Therapeutics, Inc.INDUSTRY | 1 | Jul 20, 2023 | clinicaltrials |
| NCT02889458 | Hong Kong Breast Cancer Study | active not recruiting | — | 7,000 | The University of Hong KongOTHER | 1 | May 23, 2023 | clinicaltrials |
| NCT05868252 | Molecular Analysis of the Sloane Project | unknown | — | 1,500 | King's College LondonOTHER | 1 | May 22, 2023 | clinicaltrials |
| NCT02526498 | Accelerated Partial Breast Radiation Therapy Using High-Dose Rate Brachytherapy in Treating Patients With Early Stage Breast Cancer After Surgery(TRIUMPH-T) | completed | Phase 2 | 200 | Rutgers, The State University of New JerseyOTHER | 1 | May 15, 2023 | clinicaltrials |
| NCT03268993 | Effects of Avmacol® in the Oral Mucosa of Patients Following Curative Treatment for Tobacco-related Head and Neck Cancer | completed | N/A | 6 | University of PittsburghOTHER | 1 | Apr 7, 2023 | clinicaltrials |
| NCT05218044 | Cryoablation as a Minimally Invasive Alternative to Surgery for Managing Ductal Carcinoma In Situ(DCIS) | recruiting | N/A | 30 | Glendale Adventist Medical Center d/b/a Adventist Health GlendaleOTHER | 1 | Mar 3, 2023 | clinicaltrials |
| NCT02314156 | Transdermal or Oral Telapristone Acetate in Treating Patients Undergoing Mastectomy | completed | Phase 2 | 67 | Northwestern UniversityOTHER | 1 | Feb 22, 2023 | clinicaltrials |
| NCT05724758 | Patient Reported Outcomes After Oncoplastic Breast Conserving Surgery | unknown | — | 100 | Brust-Zentrum AGOTHER | 0 | Feb 13, 2023 | clinicaltrials |
| NCT04248179 | The Ultrasound-guided Multiple-injection Costotransverse Block for Mastectomy and Primary Reconstructive Surgery. | completed | Phase 4 | 36 | Zealand University HospitalOTHER | 1 | Feb 9, 2023 | clinicaltrials |
| NCT03775213 | Acceptability of Active Monitoring (AM) as a Treatment Option for Ductal Carcinoma in Situ (DCIS) | completed | N/A | 322 | Duke UniversityOTHER | 1 | Jan 30, 2023 | clinicaltrials |
| NCT03323658 | Bexarotene in Preventing Breast Cancer in Patients at High Risk for Breast Cancer | completed | Phase 1 | 24 | National Cancer Institute (NCI)NIH | 1 | Jan 10, 2023 | clinicaltrials |
| NCT04312737 | Evaluation of in Vitro Devices on Self-collected Vaginal Swab and Urine Sample for Testing of Human Papilloma Virus(EU-VALHUDES) | completed | — | 600 | Hiantis SrlINDUSTRY | 3 | Jan 6, 2023 | clinicaltrials |
| NCT04170920 | Pilot Study of a an App to Improve Medication Adherence in Breast Cancer Survivors Receiving AIs | completed | N/A | 62 | Indiana UniversityOTHER | 1 | Sep 14, 2022 | clinicaltrials |
| NCT02039388 | Lavage of the Uterine Cavity for the Diagnosis of Serous Tubal Intraepithelial Carcinoma(LUSTIC) | completed | N/A | 701 | Medical University of ViennaOTHER | 8 | Sep 2, 2022 | clinicaltrials |
| NCT04823871 | Early Detection of High Grade Ovarian Cancer Using Uterine Lavage EHUD Study and Duplex Sequencing(EHUD) | completed | N/A | 406 | Paul Speiser, Prof.MD,OTHER | 4 | Sep 2, 2022 | clinicaltrials |
| NCT04985032 | Accelerated Partial Breast Irradiation (APBI) Using Stereotactic Body Radiation Therapy (SBRT) | recruiting | — | 200 | RPCR, Inc.OTHER | 1 | Aug 5, 2022 | clinicaltrials |
| NCT04349111 | An Efficacy Study of the Xoft® Axxent® eBx® IORT System® "Lite" | withdrawn | N/A | 0 | Xoft, Inc.INDUSTRY | 0 | Aug 2, 2022 | clinicaltrials |
| NCT02901548 | Phase 2 Durvalumab (Medi4736) for Bacillus Calmette-Guérin (BCG) Refactory Urothelial Carcinoma in Situ of the Bladder | terminated | Phase 2 | 17 | H. Lee Moffitt Cancer Center and Research InstituteOTHER | 1 | Jul 29, 2022 | clinicaltrials |
| NCT04293679 | Open Label, Dose Escalation Study for the Safety and Efficacy of STP705 in Adult Patients With isSCC | completed | Phase 1 / Phase 2 | 25 | SirnaomicsINDUSTRY | 1 | Jun 9, 2022 | clinicaltrials |
| NCT05402046 | Clinical vAlidation of a MobilE appLication ("ProRodinki") in the Assessment of the maLignant skIn neoplAsms(CAMELLIA) | unknown | N/A | 605 | MelanomaPRO, RussiaOTHER | 1 | Jun 2, 2022 | clinicaltrials |
| NCT04770974 | Urothelial Cancer Tumor Bio-markers and Physical-spectroscopic Characteristic | unknown | — | 200 | University of FlorenceOTHER | 1 | May 9, 2022 | clinicaltrials |
| NCT04666961 | Impact of Neoadjuvant Hormonal Therapy on the Surgical Management of Extensive Ductal Carcinomas in Situ(HORNEO01) | recruiting | Phase 2 | 262 | Institut Cancerologie de l'OuestOTHER | 1 | Apr 22, 2022 | clinicaltrials |
| NCT02759900 | Using a Cold Atmospheric Plasma Device to Treat Skin Disorders | unknown | N/A | 100 | The Skin Center Dermatology GroupINDUSTRY | 1 | Apr 12, 2022 | clinicaltrials |
| NCT04425291 | Evaluate the Immunogenicity and Safety of 4-valent and 9-valent HPV Recombinant Vaccine in Chinese Healthy Females | completed | Phase 3 | 1,680 | Shanghai Bovax Biotechnology Co., Ltd.INDUSTRY | 1 | Feb 25, 2022 | clinicaltrials |
| NCT05210348 | Clinical Evaluation of Detection of High Risk HPV in Urine(Urine-hrHPV) | unknown | — | 1,000 | Peking University People's HospitalOTHER | 1 | Jan 27, 2022 | clinicaltrials |
| NCT05208775 | A Comparative Study of Endoscopic Submucosal Dissection and Photodynamic Therapy for Early Esophageal Cancer | unknown | N/A | 46 | The First Affiliated Hospital of Henan University of Science and TechnologyOTHER | 0 | Jan 26, 2022 | clinicaltrials |
| NCT04866992 | Prospective Registry Trial for Single Port Robot-assisted Nipple Sparing Mastectomy (SPrNSM)(SPrNSM) | completed | — | 10 | University of Texas Southwestern Medical CenterOTHER | 1 | Jan 21, 2022 | clinicaltrials |
| NCT01849250 | Study of Docosahexaenoic Acid (DHA) in Triple Negative Breast Cancer Survivors | completed | Phase 2 | 65 | National Cancer Institute (NCI)NIH | 1 | Dec 28, 2021 | clinicaltrials |
| NCT02137252 | Naltrexone RCT for Treatment-Emergent Fatigue in Patients Receiving Radiation Therapy for Breast Cancer | terminated | Phase 2 | 3 | Dana-Farber Cancer InstituteOTHER | 1 | Nov 16, 2021 | clinicaltrials |
| NCT04245657 | Factors Affecting Functionality in Breast Cancer Survivors | completed | — | 111 | Izmir Bakircay UniversityOTHER | 1 | Nov 8, 2021 | clinicaltrials |
| NCT03834532 | Living Well After Breast Surgery | completed | N/A | 17 | University of Texas at AustinOTHER | 1 | Nov 2, 2021 | clinicaltrials |
| NCT02909426 | The Mammography and Ultrasonography STudy for Breast Cancer Screening Effectiveness(MUST-BE) | unknown | — | 11,880 | Soonchunhyang University HospitalOTHER | 1 | Oct 7, 2021 | clinicaltrials |
| NCT03931928 | Genotype and Phenotype Guided Supplementation of TAMoxifen Standard Therapy With ENDOXifen in Breast Cancer Patients(TAMENDOX) | completed | Phase 2 | 356 | Robert Bosch Gesellschaft für Medizinische Forschung mbH (RBMF)OTHER | 1 | Sep 17, 2021 | clinicaltrials |
| NCT03167762 | Photographing the Skin During Photodynamic Therapy | completed | N/A | 18 | University of DundeeOTHER | 1 | Jul 16, 2021 | clinicaltrials |
| NCT01448447 | Phase IV Trial to Evaluate Breast Brachytherapy Using the Mammosite-Ml®(Mammosite ML) | completed | N/A | 20 | Mercy ResearchOTHER | 1 | Jul 15, 2021 | clinicaltrials |
| NCT01023477 | Study of the Efficacy of Chloroquine in the Treatment of Ductal Carcinoma in Situ (The PINC Trial) | completed | Phase 1 / Phase 2 | 12 | Inova Health Care ServicesOTHER | 1 | Jun 29, 2021 | clinicaltrials |
| NCT03182959 | Broccoli Sprout Extract in Preventing Recurrence in Patients With Tobacco-Related Head and Neck Squamous Cell Cancer | completed | Early Phase 1 | 6 | University of ArizonaOTHER | 1 | Jun 21, 2021 | clinicaltrials |
| NCT00256217 | Chemoprevention Trial - Anastrozole in Ductal Carcinoma In Situ (DCIS) in Postmenopausal Women | completed | Phase 2 | 42 | Rita Sanghvi, MehtaOTHER | 1 | May 11, 2021 | clinicaltrials |
| NCT01438112 | Efficacy Study of Recombinant Adenovirus for Non Muscle Invasive Bladder Cancer(BOND) | terminated | Phase 2 / Phase 3 | 22 | CG Oncology, Inc.INDUSTRY | 1 | Apr 14, 2021 | clinicaltrials |
| NCT04798703 | Study of ONCOFID-P-B™ (PACLITAXEL-HYALURONIC ACID) | completed | Phase 1 | 20 | Fidia Farmaceutici s.p.a.INDUSTRY | 2 | Mar 17, 2021 | clinicaltrials |
| NCT03437915 | BrUOG 351: PRE-OPERATIVE APBI USING NIBB(351) | withdrawn | N/A | 0 | Jaroslaw HepelOTHER | 0 | Mar 9, 2021 | clinicaltrials |
| NCT04647981 | Diagnostic Performance Evaluation Study of the Xpert® Bladder Cancer Monitor Test.(Xpert Bladder) | completed | — | 320 | Clinique Beau SoleilOTHER | 1 | Feb 9, 2021 | clinicaltrials |
| NCT04695015 | Research of Pathological Imaging Diagnosis of Ocular Tumors Based on New Artificial Intelligence Algorithm | unknown | — | 100 | Peking UniversityOTHER | 0 | Jan 5, 2021 | clinicaltrials |
| NCT00496808 | Neoadjuvant Herceptin for Ductal Carcinoma In Situ of the Breast | completed | N/A | 69 | M.D. Anderson Cancer CenterOTHER | 1 | Sep 23, 2020 | clinicaltrials |
Data updated 23 days agoSource updated Aug 7, 2023source: clinicaltrials